MINNEAPOLIS (May 08, 2017) – Minneapolis-based pharmacogenomics company OneOme today announced it has earned a 2017 Eureka Innovation Award from the Minneapolis / St. Paul Business Journal. The Eureka Innovation awards recognize game-changing companies across Minnesota industries. OneOme earned th...
Precision Medicine Event Features OneOme’s Director of Medical Affairs
Minnesota Health Care Roundtable Takes Place April 20th from 1-4 p.m.
04/19/2017
MINNEAPOLIS (April 19, 2017) – Tomorrow, OneOme’s director of medical affairs Josiah Allen will join the Minnesota Health Care Roundtable on precision medicine. The panel, which includes local leaders in the field, takes place on Thursday, April 20, from 1 to 4 p.m. at the Downtown Minneapolis H...
OneOme’s Director of Medical Affairs to Speak on Power of Pharmacogenomics at Design of Medical Devices Conference
Josiah Allen Speaking at Emerging Technology Forum on April 13th at 10:15 a.m.
04/10/2017
MINNEAPOLIS (April 10, 2017) – On Thursday, April 13, OneOme’s director of medical affairs Josiah Allen will speak about the power of pharmacogenomics in personalized medicine at the Design of Medical Devices Conference Emerging Technology Forum. The event, which explores “Personalized Medical...
OneOme Shares Findings of Pharmacogenomics Awareness Survey
RightMed test mitigates barriers for implementing pharmacogenomics
03/27/2017
MINNEAPOLIS (March 27, 2017) – Pharmacogenomics company OneOme today announced the results of its clinician pharmacogenomic testing awareness survey. OneOme will formally share its findings at the Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy Annual Meeting, which begin...
Results from OneOme’s RightMed test now can be integrated into a patient’s Electronic Medical Record (EMR)
03/21/2017
MINNEAPOLIS (March 21, 2017) – OneOme continues to make strides to ensure its powerful pharmacogenomics testing is a lasting tool for patients and healthcare providers. Results from OneOme’s RightMed test, which analyzes an individual’s DNA to predict his or her response to medications, now ca...
